Home > Boards > US Listed > Medical - Drugs > GlaxoSmithKline (GSK)

$GSK - GlaxoSmithKline's vaccine is currently being tested

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 541
Posts 24,586
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/21/2019 6:35:01 AM
GlaxoSmithKline to Sell Two Former Novartis Vaccines for up to EUR955 Million Dow Jones News - 10/21/2019 4:12:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 1:07:57 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 1:01:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 12:54:55 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/15/2019 12:50:29 PM
European Stocks Surge To Best Level In 16 Months On Brexit Optimism, U.S. Earnings Dow Jones News - 10/15/2019 12:25:00 PM
European Stocks Surge To Best Level In 16 Months On Brexit Optimism, U.S. Earnings Dow Jones News - 10/15/2019 12:23:00 PM
Pound Surges On Report Of Possible Draft Brexit Deal Dow Jones News - 10/15/2019 11:58:00 AM
Brexit Hopes Sends British Pound To Highest Level Of Johnson Administration As U.K. Banks Soar Dow Jones News - 10/12/2019 9:44:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2019 1:32:13 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2019 12:41:17 PM
Brexit Hopes Sends British Pound To Highest Level Of Johnson Administration As U.K. Banks Soar Dow Jones News - 10/11/2019 11:55:00 AM
Brexit Hopes Sends British Pound To Highest Level Of Johnson Administration As U.K. Banks Soar Dow Jones News - 10/11/2019 10:34:00 AM
Brexit Hopes Fuel Fresh Rally For The British Pound To Highest Level Of Johnson Administration Dow Jones News - 10/11/2019 9:10:00 AM
Brexit Hopes Fuel Fresh Rally For The British Pound To Highest Level Of Johnson Administration Dow Jones News - 10/11/2019 7:56:00 AM
Brexit Hopes Fuel Fresh Rally For The British Pound Dow Jones News - 10/11/2019 7:48:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2019 12:30:05 PM
Glaxo Links Up with US Biotech to Target Solid Tumors with Cell Therapy Dow Jones News - 10/8/2019 11:26:00 AM
GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma Business Wire - 10/2/2019 9:08:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/1/2019 1:50:42 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/1/2019 11:39:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/30/2019 11:11:15 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/30/2019 7:01:33 AM
GlaxoSmithKline Says Ovarian Cancer Study Validates Tesaro Acquisition -- WSJ Dow Jones News - 9/30/2019 3:02:00 AM
KarinCA Member Level  Sunday, 10/19/14 11:42:56 PM
Re: Stock Guy777 post# 89
Post # of 140 
$GSK - GlaxoSmithKline's vaccine is currently being tested and if efficacious it could have 10,000 doses ready in a few months.

http://www.economist.com/news/international/21625813-ebola-epidemic-west-africa-poses-catastrophic-threat-region-and-could-yet
Quote:
In large part because of worries that Ebola might be used as a biological weapon, vaccines that protect lab animals against the virus were already on the shelf when the outbreak began. Two are now being tested for safety in humans, and one of them could, if it is safe, be tested for efficacy quite soon, most likely in health-care workers in west Africa. Its maker, GlaxoSmithKline, could have 10,000 doses ready in a few months.






Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist